Share
Print
A+
A-

Comen Bio develops new biotech reagent

Writer: Lin Songtao  |  Editor: Cao Zhen  |  From: Original  |  Updated: 2026-11-11

Guangming-based company Comen Bio and the School of Pharmacy at Xi’an Jiaotong University have developed a water-soluble fluorescent reagent using a technology that integrates hemolysis and staining, claiming to have overcome a longstanding global challenge in maintaining the stability of fluorescent dyes in aqueous solutions.

The reagent combines hemolytic and staining functions in a single vial and has been deployed in Comen Bio’s new-generation fluorescent blood cell analyzer, the CF9200, marking the transition of the technology from laboratory breakthrough to full-instrument integration.


Comen Bio’s new-generation fluorescent blood cell analyzer, the CF9200.

Comen Bio’s water-soluble fluorescent reagent.


Fluorescent reagents are key consumables for precise cell classification and counting in blood cell analysis. The industry has long relied on a two-vial architecture with separate hemolytic agents and staining solutions, which requires complex tubing and fluid-handling components, increasing the variety of consumables and maintenance costs. Merging the two into one vial has been a long-standing industry goal, but the poor stability of fluorescent dyes in aqueous environments has been the key bottleneck.

Comen Bio’s R&D team said the reagent applies computer-aided drug design and molecular target research methods from pharmaceutical development to optimize dye molecules at the structural level. Compared with conventional stains, the reagent is more hydrophilic, has a shelf life of 18 months and delivers better staining performance, helping improve white blood cell classification accuracy and abnormal cell identification, the company said.

The single-vial architecture simplifies instrument fluid paths, reduces hardware investment and cuts laboratory consumable stock and fluid-change operations, lowering overall user costs, according to the company.

The company said the development marks progress toward greater self-reliance in key technologies and consumables for China's blood cell analysis industry and offers a Chinese approach to advancing global reagent technology. The technology’s stability and cost-effectiveness in broader clinical settings will remain a focus for the industry.

Comen Bio and the School of Pharmacy at Xi’an Jiaotong University have developed a water-soluble fluorescent reagent using a technology that integrates hemolysis and staining.